Although the RFC3 is a tumor suppressor gene, it has been associated with poor survival in triple-negative breast cancer, ovarian tumor, lung adenocarcinoma, esophageal adenocarcinoma, hepatocellular carcinoma, suggesting that RFC3 may be a potential risk oncogenic gene involved in tumorigenesis29–34. This evidence concerns the gene RFC3 and ovarian neoplasm.